Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Market Data Solutions
Report an Issue
Market: Market:

Financial Technology & Market Data

 
No Matching Results
Advanced search
or
Menu

Ardelyx Inc (ARDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Ardelyx Reports Second Quarter 2018 Financial Results and Recent Highlights PR Newswire - Tue Aug 7, 3:01PM CDT
CMTX - Tue Aug 7, 3:01PM CDT

Ardelyx, Inc. (NASDAQ: ARDX), today reported business highlights and financial results for the second quarter ended June 30, 2018.

ARDX : 4.05 (-3.57%)
Ardelyx Reports Second Quarter 2018 Financial Results and Recent Highlights PR Newswire - Tue Aug 7, 3:01PM CDT
PRNW - Tue Aug 7, 3:01PM CDT

FREMONT, Calif. , Aug. 7, 2018 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), today reported business highlights and financial results for the second quarter ended June 30, 2018 .

ARDX : 4.05 (-3.57%)
Ardelyx, Inc. to Host Earnings Call ACCESSWIRE - Tue Aug 7, 1:42PM CDT
CMTX - Tue Aug 7, 1:42PM CDT

NEW YORK, NY / ACCESSWIRE / August 7, 2018 / Ardelyx, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 4:30 PM Eastern Time.

ARDX : 4.05 (-3.57%)
What's in Store for Penumbra (PEN) This Earnings Season? Zacks Equity Research - Zacks Investment Research - Mon Aug 6, 8:15AM CDT
Zacks Equity Research - ZACKS - Mon Aug 6, 8:15AM CDT

Penumbra (PEN) deepens focus on driving innovation, ramping up production and expanding geographies.

EYE : 43.75 (-2.56%)
NTRA : 25.49 (+1.07%)
PEN : 121.55 (-2.25%)
ARDX : 4.05 (-3.57%)
Can Dental Growth Drive Henry Schein's (HSIC) Q2 Earnings? Zacks Equity Research - Zacks Investment Research - Thu Aug 2, 10:38AM CDT
Zacks Equity Research - ZACKS - Thu Aug 2, 10:38AM CDT

Henry Schein (HSIC) is strongly placed to gain from the ongoing trend of digitalization in the global dental market.

EYE : 43.75 (-2.56%)
NTRA : 25.49 (+1.07%)
HSIC : 77.82 (+0.58%)
ARDX : 4.05 (-3.57%)
Ardelyx Announces Date of Second Quarter 2018 Financial Results and Conference Call PR Newswire - Wed Aug 1, 5:30AM CDT
PRNW - Wed Aug 1, 5:30AM CDT

FREMONT, Calif. , Aug. 1, 2018 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX) today announced that it plans to report its second quarter 2018 financial results after market close on Tuesday, August...

ARDX : 4.05 (-3.57%)
Free Technical Research Reports on Biotech Stocks -- Versartis, VIVUS, Xenetic Biosciences, and Ardelyx PR Newswire - Mon Jul 30, 5:00AM CDT
CMTX - Mon Jul 30, 5:00AM CDT

If you want a free Stock Review on VSAR, VVUS, XBIO, and ARDX sign up now at https://stocktraderreport.com/registration/. On Friday, July 27, 2018, the NASDAQ Composite closed the trading session at 7,737.42,...

VSAR : 1.65 (-4.35%)
VVUS : 0.67 (+3.08%)
XBIO : 4.08 (+28.30%)
ARDX : 4.05 (-3.57%)
Top Ranked Momentum Stocks to Buy for July 26th Zacks Equity Research - Zacks Investment Research - Thu Jul 26, 6:02AM CDT
Zacks Equity Research - ZACKS - Thu Jul 26, 6:02AM CDT

Top Ranked Momentum Stocks to Buy for July 26th

BLFS : 20.54 (+4.16%)
APOG : 49.18 (-0.02%)
ARDX : 4.05 (-3.57%)
Free Technical Reports on Array BioPharma and Three Additional Biotech Equities ACCESSWIRE - Tue Jun 26, 6:13AM CDT
CMTX - Tue Jun 26, 6:13AM CDT

Stock Research Monitor: ARDX, BOLD, and AUPH

ARRY : 14.65 (-1.01%)
BOLD : 35.17 (-2.36%)
ARDX : 4.05 (-3.57%)
Consolidated Research: 2018 Summary Expectations for CorVel, Consol Energy, Ardelyx, Aevi Genomic Medicine, Proofpoint, and Brink's -- Fundamental Analysis, Key Performance Indications GlobeNewswire - Thu May 31, 6:40AM CDT
CMTX - Thu May 31, 6:40AM CDT

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CorVel Corp. (NASDAQ:CRVL),...

GNMX : 0.98 (unch)
CRVL : 57.10 (+1.33%)
ARDX : 4.05 (-3.57%)
CEIX : 43.07 (-0.83%)
PFPT : 116.53 (-0.54%)
BCO : 77.80 (-1.95%)
Ardelyx Announces Pricing of Public Offering of Common Stock PR Newswire - Tue May 22, 5:01PM CDT
PRNW - Tue May 22, 5:01PM CDT

FREMONT, Calif. , May 22, 2018 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX) today announced the pricing of an underwritten public offering of 12,500,000 shares of its common stock at a public offering...

ARDX : 4.05 (-3.57%)
Ardelyx Raises $50 Million in Loan Agreement with Solar Capital and Bridge Bank PR Newswire - Mon May 21, 3:02PM CDT
PRNW - Mon May 21, 3:02PM CDT

FREMONT, Calif. , May 21, 2018 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), today announced it has entered into a $50.0 million senior secured term loan facility with Solar Capital Ltd. and...

ARDX : 4.05 (-3.57%)
Bruce Walton Named President and COO of Aurora Diagnostics BusinessWire - Fri May 11, 8:00AM CDT
CMTX - Fri May 11, 8:00AM CDT

Aurora Diagnostics announced today that Bruce Walton, the company's Executive Vice President and Chief Operating Officer (COO) since January 2015, has been promoted to President and COO.

ARDX : 4.05 (-3.57%)
Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights PR Newswire - Tue May 8, 3:05PM CDT
CMTX - Tue May 8, 3:05PM CDT

Ardelyx, Inc. (NASDAQ: ARDX), today reported business highlights and financial results for the first quarter ended March 31, 2018.

ARDX : 4.05 (-3.57%)
Ardelyx Inc Down 12.1% Since SmarTrend Downtrend Call (ARDX) Comtex SmarTrend(R) - Wed May 2, 12:29AM CDT
CMTX - Wed May 2, 12:29AM CDT

SmarTrend identified a Downtrend for Ardelyx Inc (NASDAQ:ARDX) on February 13th, 2018 at $5.69. In approximately 3 months, Ardelyx Inc has returned 12.13% as of today's recent price of $5.00.

ARDX : 4.05 (-3.57%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (ARDX , SGMO , FMI , INSY , KPTI ) Comtex SmarTrend(R) - Wed Apr 18, 3:20AM CDT
CMTX - Wed Apr 18, 3:20AM CDT

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

SGMO : 15.90 (+1.60%)
FMI : 136.95 (-0.04%)
ARDX : 4.05 (-3.57%)
Cascade Pathology Services Practice Joins Aurora Diagnostics BusinessWire - Mon Apr 9, 4:00PM CDT
CMTX - Mon Apr 9, 4:00PM CDT

Aurora Diagnostics announced today that Cascade Pathology Services Corp., a physician-owned multi-specialty pathology practice providing surgical pathology services to hospitals and physician...

ARDX : 4.05 (-3.57%)
Analysis: Positioning to Benefit within Euronet Worldwide, Innospec, Zosano Pharma, Ardelyx, Crown Castle International, and Aldeyra Therapeutics -- Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire - Thu Apr 5, 7:15AM CDT
CMTX - Thu Apr 5, 7:15AM CDT

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Euronet Worldwide, Inc. (NASDAQ:EEFT),...

IOSP : 74.20 (-0.93%)
ALDX : 7.70 (-0.65%)
CCI : 110.62 (+0.25%)
ARDX : 4.05 (-3.57%)
ZSAN : 4.11 (-1.20%)
EEFT : 93.92 (-0.42%)
Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada PR Newswire - Mon Mar 19, 5:30AM CDT
CMTX - Mon Mar 19, 5:30AM CDT

Ardelyx, Inc. (NASDAQ: ARDX) today announced a license agreement with Knight Therapeutics, Inc. (TSX: GUD) (Knight) that provides Knight with exclusive rights to commercialize tenapanor in Canada. Tenapanor...

GUD.TO : 8.26 (-0.84%)
ARDX : 4.05 (-3.57%)
Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada PR Newswire - Mon Mar 19, 5:30AM CDT
PRNW - Mon Mar 19, 5:30AM CDT

FREMONT, Calif. , March 19, 2018 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX) today announced a license agreement with Knight Therapeutics, Inc. (TSX: GUD) (Knight) that provides Knight with exclusive...

GUD.TO : 8.26 (-0.84%)
ARDX : 4.05 (-3.57%)
Please wait...

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
Thu Jun 21, 9:57AM CDT
EHC +0.54 , FTNT -0.51 , CAKE +0.54 , PLT +0.33 , AEO -0.09
See More
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures ended the Monday session with most contracts 1 to 2 cents in the red. The USDA reported a private export sale of 213,372 MT to Mexico this morning, with the sale split between 2018/19 (142,248 MT) and 19/20 (71,124 MT). This morning&r...
Read More

Mon Aug 13, 5:03PM CDT

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
Reserve Your Spot